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Abstract
 
Mycobacterium tuberculosis
 
 (MTB) inhibits phagosomal maturation to promote its survival inside
macrophages. Control of MTB infection requires CD4 T cell responses and major histocom-
patibility complex (MHC) class II (MHC-II) processing of MTB antigens (Ags). To investigate
phagosomal processing of MTB Ags, phagosomes containing heat-killed (HK) or live MTB
were purified from interferon-
 
 
 
 (IFN-
 
 
 
)–activated macrophages by differential centrifugation
and Percoll density gradient subcellular fractionation. Flow organellometry and Western blot
analysis showed that MTB phagosomes acquired lysosome-associated membrane protein-1
(LAMP-1), MHC-II, and H2-DM. T hybridoma cells were used to detect MTB Ag 85B(241–
256)–I-A
 
b
 
 complexes in isolated phagosomes and other subcellular fractions. These complexes
appeared initially (within 20 min) in phagosomes and subsequently (
 
 
 
20 min) on the plasma
membrane, but never within late endocytic compartments. Macrophages processed HK MTB
more rapidly and efficiently than live MTB; phagosomes containing live MTB expressed fewer
Ag 85B(241–256)–I-A
 
b
 
 complexes than phagosomes containing HK MTB. This is the first
study of bacterial Ag processing to directly show that peptide–MHC-II complexes are formed
within phagosomes and not after export of bacterial Ags from phagosomes to endocytic Ag
processing compartments. Live MTB can alter phagosome maturation and decrease MHC-II
Ag processing, providing a mechanism for MTB to evade immune surveillance and enhance its
survival within the host.
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Introduction
 
Mycobacterium tuberculosis
 
 (MTB)
 
*
 
 is an intracellular patho-
gen that survives inside macrophage phagosomal compart-
ments. CD4 T cell responses are critical to the control of
MTB infection in both animals and humans (1–4) and re-
quire processing of mycobacterial Ags to generate peptide–
MHC-II complexes. Although the CD4 T cell–dominated
immune response controls MTB infection in the majority
of otherwise healthy individuals, it does not completely
eradicate infection. A small number of bacilli survive inside
host macrophages, evading immune responses. The ability
of MTB to inhibit MHC expression and Ag presentation
may contribute to evasion of immune surveillance (5–12).
We have demonstrated that MTB 19-kD lipoprotein in-
hibits MHC-II expression and Ag processing via a mecha-
nism that is dependent on Toll-like receptor 2 (12). How-
ever, this mechanism requires hours to days to establish
inhibition and cannot alter Ag processing during initial
stages of macrophage infection. Other mechanisms, e.g.,
the ability of MTB to inhibit phagosome maturation, may
apply early after phagocytosis to enhance survival of MTB
and inhibit Ag processing.
MTB survives in phagosomes that it modifies to pro-
mote its survival. After phagocytosis of other bacteria,
phagosomes generally fuse with endosomes and eventually
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lysosomes to form phagolysosomes, a process known as
phagosome maturation. These interactions deliver host
molecules such as proteases and proton-ATPase to phago-
somes, creating an acidic, catabolic phagosomal environ-
ment. In contrast, MTB and some other slow-growing
mycobacteria (e.g., 
 
Mycobacterium bovis
 
 and 
 
Mycobacterium
avium
 
) inhibit phagosomal maturation, decreasing phago-
somal acidification, fusion of phagosomes with lysosomes,
and phagosomal acquisition of lysosomal markers and
characteristics (13–19). Thus, phagosomes containing live
mycobacteria stain intensely for markers of early endo-
somes or immature phagosomes (e.g., transferrin receptor
and rab 5), but only weakly for markers of late endosomes,
lysosomes, and mature phagolysosomes (e.g., CD63, lyso-
some-associated membrane protein [LAMP-1], LAMP-2,
and cathepsin D) (15, 20, 21). Loss of maturation is also as-
sociated with phagosome retention of tryptophan aspar-
tate–containing coat (TACO), a coat protein of unknown
function (22).
CD4 T cell responses to MTB require processing of
MTB Ags for presentation by class II MHC (MHC-II)
molecules. Newly synthesized MHC-II molecules bind in-
variant chain in the endoplasmic reticulum and target to
endocytic compartments that function in Ag processing,
e.g., the MHC class II compartment (MIIC) and class II
vesicle (CIIV) (23–29). Despite their specific names and
properties, these compartments correspond to conventional
endocytic compartments (30). They contain molecules in-
volved in Ag processing, e.g., MHC-II, invariant chain,
H2-DM (in mice) or HLA-DM (in humans), and proteases
that degrade internalized Ags to produce antigenic pep-
tides. After its delivery to endocytic compartments, invari-
ant chain is degraded, leaving only the class II–associated
invariant chain peptide (CLIP) bound to MHC-II (31).
H2-DM then catalyzes the replacement of CLIP with anti-
genic peptide, and the resulting peptide–MHC-II com-
plexes are transported to the cell surface for presentation to
CD4 T cells.
While endocytic processing of soluble Ags has been
studied extensively, less is known about processing of par-
ticulate Ags and the specific roles of phagosomes in this
process (phagosomes are defined here to include phagoly-
sosomes). We have recently studied the role of latex-bead
phagosomes in Ag processing. Latex bead phagosomes con-
tain MHC-II, invariant chain, and H2-DM, degrade
phagosome-associated Ag, and directly mediate the forma-
tion of peptide–MHC-II complexes (32–34). In addition,
latex-bead phagosomes acquired both newly synthesized
and recycling MHC-II molecules, but primarily used
newly synthesized molecules for phagocytic Ag processing
(35). However, little is known about the antigen processing
functions of phagosomes that contain pathogenic bacteria.
MTB and 
 
M. avium
 
 phagosomes have been shown to con-
tain MHC-II molecules (15, 36), but their role in Ag pro-
cessing remains undefined.
To investigate the role of MTB phagosomes in Ag pro-
cessing, we used an I-A
 
b
 
–restricted T hybridoma cell line,
BB7, specific for an epitope (241–256) from the 30-kD
 
MTB Ag 85B protein (12). Ag 85B is conserved across my-
cobacterial species and belongs to the Ag 85 family of pro-
teins that function in cell wall mycolic acid synthesis; it is
associated with the bacterial cell wall and is also released
into the surrounding medium (37–39). Ag 85B is a major
target of human T cell response to MTB and a leading vac-
cine candidate (38, 40). Presentation of Ag 85B to BB7 T
cells required phagocytosis of MTB and H2-DM–depen-
dent intracellular processing. Flow organellometry and
Western blotting demonstrated MHC-II and H2-DM in
isolated MTB phagosomes derived from IFN-
 
 
 
 activated
macrophages. Subcellular fractionation coupled with a T
cell assay demonstrated that Ag 85B(241–256)–I-A
 
b
 
 com-
plexes were initially found only in MTB phagosomes and
later appeared on the plasma membrane. Phagosomes con-
taining live MTB were found to contain fewer Ag
85B(241–256)–I-A
 
b
 
 complexes than phagosomes contain-
ing heat-killed (HK) MTB, indicating that live MTB in-
hibited phagocytic Ag processing. This is the first direct
demonstration that peptide–MHC-II complexes are formed
within bacterial phagosomes and export of bacterial Ags
from phagosomes to endocytic Ag processing compart-
ments is not required. Moreover, MHC-II Ag processing
function is altered by live MTB, providing a mechanism
for this intracellular pathogen to evade immune surveil-
lance and survive within the host.
 
Materials and Methods
 
Cells and Media.
 
B6D2F1/J and C57BL/6 mice were ob-
tained from The Jackson Laboratory. H2-DM
 
 
 
/
 
 
 
 mice (L. Van
Kaer, Vanderbilt University, Nashville, TN) were bred under
specific pathogen-free conditions. Incubations in the absence of
MTB were performed at 37
 
 
 
C in 5% CO
 
2
 
 in standard medium
composed of DMEM (Life Technologies) supplemented with
10% decomplemented fetal calf serum (Hyclone), 5 
 
 
 
 10
 
 
 
5
 
 M
2-ME, 
 
l
 
-arginine HCl (116 mg/l), 
 
l
 
-asparagine (36 mg/l),
NaHCO
 
3
 
 (2 g/liter), sodium pyruvate (1 mM), 10 mM HEPES
buffer, and antibiotics. For incubations with MTB, standard me-
dium was modified by use of non-decomplemented fetal calf se-
rum, addition of 1% non-decomplemented normal mouse serum
(Sigma-Aldrich) and absence of antibiotics. Bone marrow macro-
phage precursors were harvested from femurs of B6D2F1/J mice
and cultured for 7 d in 6-well plates in standard medium supple-
mented with 20% LADMAC (41) cell-conditioned medium.
Macrophages were then stimulated for 48 h with 50 U/ml re-
combinant IFN-
 
 
 
 (Genzyme). The resulting confluent cultures
contained 
 
 
 
1.5 
 
  
 
10
 
6
 
 cells/well. The T cell hybridoma BB7 (12)
recognizes MTB Ag 85B(241–256) bound to I-A
 
b
 
. The T cell
hybridoma DOBW (42) recognizes OVA (323–339) bound to I-A
 
d
 
(or to a lesser degree I-A
 
b
 
).
 
Antibodies.
 
Hybridoma supernatants were prepared from the
following cell lines: 1D4B (Developmental Studies Hybridoma
Bank, Johns Hopkins University, Baltimore, MD, and Univer-
sity of Iowa, Iowa City, IA), producing a rat IgG2a specific for
murine LAMP-1; 34–5-3S (American Type Culture Collection),
producing a murine IgG2a which recognizes both I-A
 
d
 
 and I-A
 
b
 
;
10.2.16 (American Type Culture Collection), producing a mu-
rine IgG2a which recognizes I-A
 
k
 
; Y-3P (American Type Cul-
ture Collection), producing a murine IgG2a which recognizes 
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I-A
 
b
 
. Some Abs were purified by protein A-affinity chromatogra-
phy. Purified Y-3P was iodinated by the chloramine T method.
 
Bacteria.
 
MTB H37Ra (American Type Culture Collection)
was grown to OD of 0.2 to 0.3 in Middlebrook 7H9 broth
(Difco) supplemented with 1% glycerol, 0.05% Tween (Sigma-
Aldrich; to prevent clumping) and 10% Middlebrook oleic albu-
min dextrose catalase (OADC) enrichment (Difco). Bacteria were
harvested and used the same day (for all experiments with live
MTB) or frozen at 
 
 
 
70
 
 
 
C as described (3). Bacterial viability was
determined by counting total MTB in Petroff-Hauser chambers
and calculating live MTB titers from CFU determinations on
Middlebrook 7H11 plates. Additionally, bacterial suspensions
were stained with fluorochromic substrates differentiating be-
tween live and dead bacteria (BacLight; Molecular Probes). Both
analyses revealed MTB viability of 
 
 
 
90%. HK MTB were pre-
pared by incubating MTB at 80
 
 
 
C for 30 min (killing was con-
firmed by absence of CFUs). Prior to macrophage infection, all
MTB preparations were pelleted, washed, declumped by two
passages through an 18-guage needle and three passages through a
22-gauge needle, and centrifuged at 150 
 
g
 
 for 5 min to remove
clumps. To label HK and live MTB with fluorescein, 10
 
9
 
 bacteria
were pelleted, resuspended in 1 ml PBS (pH 9.1) and combined
with 25 
 
 
 
l of 20 mg/ml FLUOS (Boehringer) in DMSO for 5
min at room temperature. Labeled MTB were washed twice in
DMEM and declumped before use. This procedure produced no
significant change in viability of MTB. Both HK and live MTB
were incubated in medium containing 10% non-heat treated FCS
and 1% non-heat treated normal mouse serum with no antibiotics
for 20 min at 37
 
 
 
C before incubation with cells.
 
Ag Processing and Presentation Assays.
 
Macrophages were re-
plated in 96-well flat bottom plates at 2 
 
 
 
 10
 
5
 
 cells/well before
stimulation with IFN-
 
 
 
 for 2 d. HK or live MTB was added in a
final volume of 100 
 
 
 
l. Bacteria were pelleted onto cells by cen-
trifugation at 900 
 
g
 
 for 10 min at 37
 
 
 
C. Cells were incubated at
37
 
 
 
C for 10 min (providing a total pulse period of 20 min) and
washed in ice-cold DMEM to remove extracellular bacteria. Pre-
warmed medium was added, and cells were incubated at 37
 
 
 
C for
up to 100 min. Macrophages were fixed with 1% paraformalde-
hyde and washed. T hybridoma cells (10
 
5
 
) were added to each
well (200 
 
 
 
l total volume) and incubated for 24 h. Supernatants
(100 
 
 
 
l) were harvested and assessed for IL-2 using a CTLL-2
proliferation assay, monitored by addition of Alamar blue (Alamar
Biosciences) as an indicator dye, and measured as the difference
between absorbance at 550 nm and 595 nm after 24 h. Blanks for
spectrophotometry were provided by wells containing medium
alone (added at initiation of CTLL-2 assay) and Alamar blue
(added at the same time as for the other wells). All analyses were
performed in triplicate.
 
Percoll Density Gradient Fractionation for T Cell Assay and Bio-
chemical Analysis.
 
Three 6-well plates containing confluent mac-
rophage cultures were used for each fractionation, and plates were
processed as above to achieve a 20 min pulse with MTB (multi-
plicity of infection [MOI] 
 
 
 
 40) and various chase incubations.
To identify MIIC endocytic vesicles, macrophages were incu-
bated with soluble OVA (Sigma-Aldrich) at 3 mg/ml for 1 h be-
fore the addition of bacteria. Cells were washed, detached by
scraping, washed, resuspended in homogenization buffer (0.25 M
sucrose and 10 mM HEPES, pH 7.2), and homogenized in a
Dounce homogenizer (Kontes Co.) to obtain 80 to 85% lysis (32,
33). Intact cells and nuclei were removed by 3 consecutive spins
at 200 
 
g
 
 for 5 min at 4
 
 
 
C, and the supernatant (containing phago-
somes) was collected. In some experiments, phagosomes were
pelleted from the supernatant at 500 
 
g
 
 at 4
 
 
 
C for 15 min and re-
 
suspended in 1 ml homogenization buffer. 1 ml of sample (ho-
mogenate or resuspended phagosomes) was layered on 9 ml of
27% or 40% Percoll in homogenization buffer and centrifuged in
a Ti50 fixed angle rotor (Beckman Instruments) at 4
 
 
 
C for 60
min at 36,000 
 
g
 
. The gradients were manually fractionated from
the top into 30 fractions of 333 
 
 
 
l, which were divided into rep-
licate aliquots of 10, 30, or 50 
 
 
 
l and frozen at 
 
 
 
80
 
 
 
C.
Plasma membrane was marked before homogenization by in-
cubation of macrophages for 60 min at 4
 
 
 
C with 
 
125
 
I-labeled
Y-3P (33). 
 
 
 
-hexosaminidase activity was measured by combin-
ing 50 
 
 
 
l fraction, 150 
 
 
 
l assay buffer (0.1M MES, 0.2% Triton
X-100, pH 6.5) and 50 
 
 
 
l p-nitrophenyl-acetyl-b-D-glucosaminide
(Sigma-Aldrich; 1.36 mg/ml in water) for 90 min at 37
 
 
 
C (33).
Reaction samples (100 
 
 
 
l) were combined with 100 
 
 
 
l stop
buffer (0.5 M glycine, pH 10), and OD was determined at 405
nm. To identify fluorescein-labeled bacteria, fractions (50 
 
 
 
l)
were transferred to 96-well clear-bottom black plates (Costar)
and analyzed on a Spectra Fluor Plus fluorimeter (Tecan). For T
cell analysis of Percoll gradient fractions, standard medium and
BB7 or DOBW cells (10
 
5
 
/well) were added to a final volume of
200 
 
 
 
l in 96-well plates (FCS was added to maintain 10% FCS).
After 24 h, T cell responses were assessed as above. Wells con-
taining only equivalent amounts of Percoll, BB7 cells, and me-
dium were used to generate control supernatants and blanks for
the CTLL assay.
 
Preparation of Phagosomes for Flow Organellometry.
 
Two 6-well
plates containing confluent macrophage cultures were used for
each condition. Fluorescein-labeled bacteria were added (MOI 
 
 
 
40) to achieve 20 min pulse and various chase incubations. Cells
were washed, detached by scraping, washed, and resuspended in
homogenization buffer with protease inhibitors (1.0 mM phenyl-
methylsulfonyl fluoride, 1 
 
 
 
g/ml pepstatin, and 20 
 
 
 
g/ml leu-
peptin). Cells were homogenized, intact cells and nuclei were re-
moved by centrifugation, and phagosomes were pelleted as
above. Phagosomes were resuspended and isolated on 27% Per-
coll density gradients. Fractions containing phagosomes were
identified visually and combined with an equal volume of 2%
paraformaldehyde for 10 min. The suspension was mixed with an
equal volume of 0.4 M lysine in PBS, and phagosomes were
washed twice by pelleting and resuspension in 0.5 ml PBS (32).
Phagosomes (80–100 
 
 
 
l/well) were stained in 96-well round
bottom plates using a buffer containing saponin to allow access to
lumenal epitopes (32, 33), pelleted by centrifugation at 1,900 
 
g
 
and analyzed using a COULTER EPICS Elite ESP instrument
(Beckman Coulter).
 
Results
 
Characterization of MTB Processing and Presentation.
 
Pro-
cessing of MTB was studied in bone marrow macrophages
using an MTB-specific T hybridoma, BB7, which recog-
nizes MTB Ag 85B(241–256)–I-A
 
b
 
 complexes (12). Mac-
rophages processed both soluble Ag 85B (data not shown)
and whole MTB (Fig. 1) for presentation to BB7. To con-
firm that uptake of MTB and intracellular processing were
required, macrophages were incubated with or without 10
 
 
 
g/ml cytochalasin D (to inhibit phagocytic uptake) or 100
 
 
 
M chloroquine (to inhibit acidification of vacuolar com-
partments) beginning 15 min before the addition of bacte-
ria. Cytochalasin D and chloroquine both blocked process-
ing of HK MTB (Fig. 1 A), demonstrating that phagocytic 
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uptake and intracellular processing of bacteria were re-
quired for production of Ag 85B(241–256)–I-A
 
b
 
 com-
plexes. Processing also required H2-DM, as Ag 85B(241–
256)–I-A
 
b
 
 complexes were not generated in macrophages
derived from H2-DM
 
 
 
/
 
 
 
 mice (Fig. 1 B). Thus, formation
of Ag 85B(241–256)–I-A
 
b
 
 complexes required phagocyto-
sis and H2-DM–dependent intracellular processing of
MTB bacilli.
 
Preparative Isolation of Phagosomes for Flow Analysis by
Percoll Density Gradient Centrifugation.
 
Studies of phago-
somal Ag processing require analysis of phagosomes with
exclusion of other organelles. We have used flow organel-
lometry to analytically separate and characterize latex bead
phagosomes without their prior purification (32, 33).
However, early studies with MTB phagosomes revealed
that contamination of phagosomes with other membranes
occurred unless phagosomes were purified on Percoll den-
sity gradients before immunolabeling and flow organel-
lometry. Macrophages were initially incubated with solu-
ble OVA to label MIIC vesicles with OVA(323–339)–I-A
 
d
 
complexes and then incubated with fluorescein-labeled
HK MTB for 20 min, followed by a 30-min chase. The
plasma membrane was then marked by incubation with
 
125
 
I-Y-3P (anti–I-A
 
b
 
) at 4
 
 
 
C, cells were homogenized, and
phagosomes and other organelles were separated on 27%
Percoll density gradients. Phagosomes consistently ap-
peared in fractions 27–29 in the high-density region of
27% Percoll gradients (Fig. 2 A), whereas plasma mem-
brane radioactivity was found in fractions 8 to 12 in the
low-density region (Fig. 2 B). Absence of radioactivity in
phagosomal fractions showed that phagosomes were not
contaminated by plasma membrane or intact cells (phago-
somal fractions contained less than 0.015% of the plasma
membrane label).  -hexosaminidase, a lysosomal enzyme,
was primarily found in high-density phagolysosomal/lyso-
somal fractions (Fig. 2 C, fractions 23 to 29). DOBW T hy-
bridoma cells detected OVA(323–339)–I-Ad complexes in
MIIC endocytic vesicles in fractions 23 to 28 and on the
plasma membrane in fractions 8 to 12 (Fig. 2 D). Thus, the
Figure 1. Requirements for processing of MTB bacilli for presentation
of MTB Ag 85B. Macrophages were pulsed with HK MTB for 20 min,
chased for 10 min at 37 C, and fixed. BB7 T hybridoma cells were used
to detect Ag 85B(241–256)–I-Ab complexes. Supernatants were assessed
for IL-2 content using a CTLL-2 proliferation assay that was monitored
with Alamar blue, an indicator dye. (A) Effects of cytochalasin D (10  g/
ml) and chloroquine (100  M) on Ag processing. (B) Comparison of
processing of HK MTB by B6D2 and H2-DM /  macrophages. Data
points are means of triplicate samples   SD.
Figure 2. Characterization of MTB phagosomes isolated on 27% Per-
coll density gradients. Macrophages were incubated with soluble OVA (3
mg/ml) for 1 h, incubated with fluorescein-labeled HK MTB and OVA
for 20 min, washed, chased for 30 min at 37 C in the presence of soluble
OVA, homogenized, and fractionated on 27% Percoll gradients. (A) Dis-
tribution of HK MTB phagosomes detected by fluorimetry. (B) Distribu-
tion of plasma membrane radioactivity when macrophage plasma mem-
branes were labeled with 125I-Y-3P (anti–I-Ab) at 4 C before
fractionation. (C) B-Hexosaminidase activity (a marker of lysosomal en-
zyme distribution). (D) Distribution of OVA(323–339)–I-Ad complexes
assessed by DOBW T hybridoma assay.1425 Ramachandra et al.
distributions of phagosomes and MIIC vesicles partially
overlapped in fractions 27 and 28 on 27% Percoll gradi-
ents. Similar results were obtained with phagosomes con-
taining live MTB (data not shown).
Flow organellometry of MTB phagosomes required fur-
ther purification of phagosomes before fixation to reduce
their contamination with MIIC. Density gradients with a
higher percentage of Percoll (e.g., 40%) provided better
separation of phagosomes and MIIC vesicles for other
types of studies (below), but the higher percentage of Per-
coll interfered with some procedures for flow organellom-
etry (e.g., fixation and pelleting of phagosomes). Conse-
quently, differential centrifugation (500 g for 15 min at
4 C) was used to pellet phagosomes and separate them
from MIIC before isolation of phagosomes on 27% Percoll
gradients (MIIC was detected with DOBW T hybridoma
cells as in Fig. 2 D). The combination of differential cen-
trifugation with fractionation on 27% Percoll density gra-
dients substantially decreased MIIC contamination of
phagosomes (data not shown), and the lack of contamina-
tion of phagosomes with other MHC-II–expressing mem-
branes (including MIIC) was confirmed in flow organel-
lometry studies (below).
Assessment of LAMP-1 and MHC-II Expression in Isolated
Phagosomes Containing Live or HK MTB by Flow Organellom-
etry. For flow organellometry, gating on optical scatter
properties alone was not sufficient to define MTB phago-
somes, unlike latex bead phagosomes analyzed in previous
studies (32, 33). Therefore, fluorescein-labeled bacteria
were used to prepare phagosomes that could be identified
during flow organellometry by gating on both scatter
properties and fluorescein signal. Macrophages were pulsed
with fluorescein-labeled live or HK MTB for 20 min,
washed, chased for 10 or 100 min and homogenized.
Phagosomes were pelleted, purified on 27% Percoll gradi-
ents, fixed, permeabilized with saponin to allow access to
lumenal epitopes, and immunolabeled as described previ-
ously (32, 33).
Acquisition of LAMP-1 was used as a marker for phago-
somal maturation (Fig. 3). After a 10-min chase incubation,
HK MTB phagosomes showed positive staining for
LAMP-1 with mean fluorescence value (MFV) of 344 (Fig.
3 B). A chase incubation of 100 min increased MFV for
LAMP-1 by 125% to 773 (Fig. 3 F). In contrast to the re-
sults with HK MTB, phagosomes from macrophages ex-
posed to live MTB showed less acquisition of LAMP-1.
Between 10 and 100 min of chase incubation, MFV for
LAMP-1 staining of live MTB phagosomes increased from
348 to 453 (by only 30%). Furthermore, much of this in-
crease was due to acquisition of low to moderate levels of
LAMP-1 by phagosomes with previously negative or low
LAMP-1 expression, as opposed to further acquisition
of LAMP-1 to high levels; the MFV of LAMP-1 positive
events (gate H2) increased by only 6% (from 454 to 483;
Fig. 3, J and N). Thus, phagosomes containing both live
and HK MTB acquired at least low levels LAMP-1, but
live MTB phagosomes did not acquire the high level of
LAMP-1 staining seen with HK MTB phagosomes after
longer chase incubations (e.g., 100 min). These data reflect
other observations that phagosome acquisition of LAMP-1
is decreased but not eliminated by live MTB (but not HK
MTB) (15), consistent with inhibition of phagosome matu-
ration (13) (see Discussion).
Phagosomes were also evaluated for expression of
MHC-II (Fig. 3). After a 10-min chase, HK MTB phago-
somes showed positive staining with 34–5-3S (MFV   16;
Fig. 3 D) relative to the isotype-matched negative control
Ab (MFV   3.9). When the chase time was increased to
100 min, no consistent increase in MHC-II was observed
(despite the small increase in Fig. 3; evaluation of MFV
over three experiments showed no consistent change in
MFV between 10 and 100 min of chase incubation). Fur-
thermore, phagosomes containing live MTB also con-
tained MHC-II molecules at levels that remained un-
changed between 10 and 100 min of chase (Fig. 3, L and P;
MFV of 20.4 for both). Thus, the mean level of MHC-II
expression remained relatively constant within this time
frame, although individual phagosomes varied widely in
MHC-II content.
To confirm that phagosomal staining for MHC-II mole-
cules reflected true phagosomal composition, as opposed to
contamination of phagosomes with MHC-II from other
membranes during homogenization and subcellular frac-
tionation, the purity of phagosomes was analyzed in cross
contamination experiments (Fig. 4). B6D2 macrophages
(expressing I-Ab and I-Ad) were exposed to fluorescein-
labeled HK MTB and then mixed with naive CBA/J mac-
rophages (expressing I-Ak; not exposed to HK MTB)
before homogenization. Immunolabeling of B6D2 phago-
somes for I-Ak molecules was used to assess contamination
of phagosomes by other membranes expressing MHC-II.
B6D2 phagosomes prepared after mixing B6D2 and CBA/J
macrophages showed essentially negative staining for I-Ak
(MFV   7.3, 7% in positive gate; Fig. 4 I), similar to nega-
tive control B6D2 phagosomes (from B6D2 cells not ex-
posed to CBA/J cells; MFV   6.0, 9% of events in positive
gate; Fig. 4 C). Thus, MFV and percent of events positive
for I-Ak indicate that B6D2 phagosomes had essentially no
detectable contamination by CBA/J membranes present in
the same homogenate. We conclude that our protocol
for subcellular fractionation and flow organellometry pro-
duced phagosomes with negligible contamination from
other MHC-II–expressing membranes, and MHC-II mol-
ecules detected by flow organellometry reflected true phago-
somal MHC-II content.
Western Blot Analysis of Phagosomes for H2-DM and Invari-
ant Chain. Phagosomal levels of H2-DM and invariant
chain were determined by Western blot analysis, as the
H2-DM–specific antiserum was not effective for flow
organellometry. Phagosomes were prepared by differen-
tial centrifugation and isolation on 40% Percoll density
gradients, which provided better separation of MIIC
and phagosomes (below) than the 27% Percoll gradients
used to prepare phagosomes for flow organellometry
(40% Percoll gradients interfered with the latter proce-
dure). After a 20-min pulse and 10-min chase, phago-1426 Formation of Peptide–MHC Complexes in M. tuberculosis Phagosomes
somes containing live or HK MTB expressed H2-DM
but none of the detectable forms of invariant chain (data
not shown; the antibody used, In-1, detects p41 and
p33 forms of invariant chain and a degradation interme-
diate, p10, but not CLIP). The absence of invariant
chain from MTB phagosomes suggests that there is little
delivery of invariant chain–MHC-II complexes to
MTB phagosomes or that invariant chain is rapidly de-
graded after delivery to MTB phagosomes (it also indi-
cates absence of significant contamination of phago-
somes by endoplasmic reticulum, which contains most
invariant chain).
Analysis of Subcellular Fractions for Ag 85B(241–256)–I-Ab
Complexes Using a T Cell Assay. Although MTB phago-
somes were found to contain MHC-II molecules, it was
still unclear whether peptide–MHC-II complexes were
actually formed within phagosomes or rather within en-
docytic vesicles (e.g., MIIC) that received phagosome-
derived Ag fragments. To determine the site where MTB Ag
85B(241–256)–I-Ab complexes were formed during MTB
processing, we used a technique previously developed to
detect peptide–MHC-II complexes in latex-bead phago-
somes and other organelles (24, 33, 43). This approach
uses subcellular fractionation to isolate organelle mem-
Figure 3. Arrest of phagosomal matura-
tion in MTB phagosomes containing live
but not HK MTB. Macrophages were incu-
bated with fluorescein-labeled live or HK
MTB for a 20-min pulse with a 10- or 100-
min chase incubation. Phagosomes were
pelleted, purified on 27% Percoll gradients,
and prepared for flow organellometry with
staining for LAMP-1 and MHC-II (I-Ab/d).
Events were gated for fluorescence and scat-
ter parameters consistent with phagosomes.
Staining with isotype-matched negative
control Abs was used to define the H1 gate.
The H2 gate represents positive events. The
H3 gate represents all events. MFV values
represent the mean for the H3 gate.1427 Ramachandra et al.
branes, which are then disrupted by freezing and thawing
to expose the lumenal Ag presenting domain of MHC-II
molecules and then probed for specific peptide–MHC-II
complexes using T cells. Macrophages were pulsed for 20
min with HK MTB, chased for either 0 or 220 min and
fractionated on 27% Percoll gradients. Fractions were in-
cubated with BB7 T hybridoma cells, and detection of Ag
85B(241–256)–I-Ab complexes was monitored by IL-2 se-
cretion (Fig. 5). When macrophages were pulsed with HK
MTB for 20 min with no chase incubation, Ag 85B(241–
256)–I-Ab complexes were detected primarily in phago-
somal fractions with little expression on the plasma mem-
brane (Fig. 5 A), although complexes appeared on the
plasma membrane soon thereafter and could be detected at
low levels by 20 min in some experiments. With a 20 min
pulse and 10–100 min chase incubation, Ag 85B(241–
256)–I-Ab complexes were detected in both phagosomal
and plasma membrane fractions (Fig. 5 C, and data not
shown). When the chase incubation was increased to 220
min, Ag 85B(241–256)–I-Ab complexes were detected
Figure 4. MTB phagosomes have negligible contamina-
tion with other MHC-II expressing membranes. B6D2
and CBA/J macrophages were pulsed with fluorescein-
labeled HK MTB for 20 min, washed, and chased for 30
min at 37 C. Half of the MTB-infected B6D2 macro-
phages were mixed with an equal number of naive CBA/J
macrophages before homogenization. Homogenates were
prepared from MTB-exposed B6D2 macrophages, MTB-
exposed CBA/J macrophages, and MTB-exposed B6D2
macrophages mixed with naive CBA/J macrophages. Phago-
somes were pelleted, purified on separate 27% Percoll gra-
dients, fixed, and stained for I-Ad/b or I-Ak. Flow organel-
lometry was performed as in Fig. 3.
Figure 5. Ag 85B(241–256)–I-Ab complexes are ini-
tially found in phagosomes and later appear on the
plasma membrane (PM). (A and B) Macrophages were
pulsed with HK MTB (MOI   40) for 20 min,
washed, chased for various periods, and fractionated on
27% Percoll density gradients. (C) Macrophages were
incubated with soluble OVA for 1 h and then pulsed
with HK MTB and OVA for 20 min, washed, chased
for 10 min at 37 C in the presence of OVA, and frac-
tionated on 40% Percoll density gradients. Aliquots (50
 l) of each fraction were frozen, thawed, and analyzed
for Ag 85B(241–256)–I-Ab and OVA(323–339)–I-Ad
complexes using BB7 and DOBW T hybridoma cells,
respectively. Diagrams at the top summarize the posi-
tions of different compartments in the Percoll gradients.1428 Formation of Peptide–MHC Complexes in M. tuberculosis Phagosomes
primarily in plasma membrane fractions (Fig. 5 B). When
0.5  M Ag 85B(241–256) peptide was added to the frac-
tions during the T cell assay, BB7 cells responded to all
fractions containing MHC-II, providing a positive control
and confirming the ability of BB7 cells to respond to all
such fractions when Ag 85B(241–256)–I-Ab complexes
were present (data not shown). We conclude that Ag
85B(241–256)–I-Ab complexes are formed directly in
MTB phagosomes before their expression on the plasma
membrane.
To confirm that Ag 85B(241–256)–I-Ab complexes
were being formed in phagosomes and not MIIC, macro-
phages were fractionated on 40% Percoll gradients to
achieve better separation of phagosomes and MIIC (Fig. 5
C). Prior to fractionation, macrophages were incubated
with soluble OVA for 1 h, pulsed with HK MTB for 20
min, chased for 10 min, and fractionated on 40% Percoll
gradients. BB7 T hybridoma cells detected Ag 85B(241–
256)–I-Ab complexes in phagosomal fractions (25 to 27)
and plasma membrane fractions (7 to 10) (Fig. 5 C).
DOBW cells detected OVA(323–339)–I-Ad complexes in
MIIC fractions (17 to 23) and plasma membrane fractions
(6 to 10). As fractions containing MIIC and phagosomes
were well separated on 40% Percoll gradients, Ag
85B(241–256)–I-Ab complexes were clearly formed in
phagosomes and not late endocytic compartments.
Comparison of Phagosomal Processing of Live versus HK
MTB. As previous studies have shown that phagosomal
maturation is inhibited to a greater degree by live MTB
than HK MTB, we investigated the processing of live ver-
sus HK MTB by IFN-  activated macrophages for presen-
tation to T cells. Macrophages were incubated with live or
HK MTB for 20 min, washed, chased for various periods,
fixed, and incubated with BB7 T hybridoma cells to assess
the presentation of Ag 85B(241–256)–I-Ab complexes.
Processing of HK MTB was initiated rapidly, and Ag
85B(241–256)–I-Ab complexes were expressed at low lev-
els on the cell surface by 20 min with high MOI (Fig. 6).
At early time points, BB7 cells responded better to macro-
phages infected with HK than live MTB. However, at later
time points (100 min chase), BB7 cells responded similarly
to macrophages incubated with either live or HK MTB.
We conclude that IFN-  activated macrophages processed
both live and HK MTB, but processing of HK MTB was
more rapid and efficient than processing of live MTB. Fur-
thermore, these studies may understate the inhibition of
processing that live MTB may achieve in less activated
macrophages, since activation of macrophages with IFN- 
may enhance maturation of all phagosomes and decrease
differences between live and HK MTB phagosomes, as has
been shown in other systems with IFN-  alone or in com-
bination with other agents (36, 44–47).
We next determined if differences in processing of live
versus HK MTB by macrophages correlated with the effi-
ciency of phagosomal processing as reflected by the levels
of Ag 85B(241–256)–I-Ab complexes expressed in the two
types of phagosomes. Macrophages were pulsed with live
or HK MTB for 20 min at MOI of 13 or 40 bacteria per
cell. Infected macrophages were fractionated on 27% Per-
coll gradients, and Ag 85B(241–256)–I-Ab complexes were
detected in fractions with BB7 T hybridoma cells. At MOI
of 13, BB7 cells responded only to fractions containing HK
MTB phagosomes but not to fractions containing live
MTB phagosomes (Fig. 7 A). When the MOI was in-
creased to 40, BB7 cells responded to fractions containing
both live and HK MTB phagosomes (Fig. 7 B). Even at
this early time point, BB7 cells detected Ag 85B(241–256)–
I-Ab complexes in plasma membrane fractions from macro-
phages pulsed at MOI of 40 with HK MTB, but detectable
presentation of complexes in plasma membrane was not
achieved with live MTB (Fig. 7 B). The mean uptake of
bacteria per macrophage in different experiments was 4–5
at MOI of 13 and 13–15 at MOI of 40 (data not shown),
and uptake of live versus HK MTB by macrophages was
similar (data not shown). Therefore, when the number of
phagosomes in fractions 26 to 28 was low (MOI of 13),
phagosomes containing HK MTB expressed sufficient Ag
85B(241–256)–I-Ab complexes to drive detectable BB7 re-
sponses, but fractions containing live MTB phagosomes
contained too few Ag 85B(241–256)–I-Ab complexes to
generate a BB7 response with this number of phagosomes.
With the greater number of phagosomes produced at MOI
of 40, the total number of complexes in the phagosomal
Figure 6. HK MTB is processed more rapidly than live MTB. Macro-
phages were pulsed with HK or live MTB for 20 min, chased for varying
periods at 37 C, and fixed. BB7 T hybridoma cells were used to detect
presentation of Ag 85B(241–256)–I-Ab complexes (see Fig. 1). (A) Pre-
sentation at varying MOI after 0- or 100-min chase. (B) Presentation after
varying chase intervals with MOI   5. A and B are from a single experi-
ment. Data points are means of triplicate samples   S.D.1429 Ramachandra et al.
fractions sufficed to generate a BB7 response to both live
and HK MTB phagosomes. These observations suggest that
phagosomes containing HK MTB generate Ag 85B(241–
256)–I-Ab complexes more rapidly and efficiently than
phagosomes containing live MTB.
Cross contamination control experiments were per-
formed to confirm that Ag 85B(241–256)–I-Ab complexes
were formed within intracellular live MTB phagosomes
and not after homogenization as an artifact of protease re-
lease, extracellular Ag proteolysis and peptide binding to
MHC-II. CBA/J macrophages (expressing I-Ak) were
pulsed with live MTB (MOI   40) for 20 min, washed,
and chased for an additional 20 min. These cells were
mixed with an equal number of naive B6D2 macrophages
(expressing I-Ab but not pulsed with live MTB), homoge-
nized, and fractionated on a 27% Percoll gradient to allow
for potential formation of Ag 85B(241–256)–I-Ab com-
plexes as an artifact after homogenization. Ag 85B(241–
256)–I-Ab complexes were detected in fractions with BB7
T hybridoma cells (Fig. 7 C). These results were compared
with BB7 responses to phagosomes from B6D2 macro-
phages that were similarly pulsed with live MTB. BB7 cells
responded strongly to MTB phagosomes from B6D2 mac-
rophages but showed minimal response to phagosomal
fractions prepared after mixing infected CBA/J and unin-
fected B6D2 macrophages (despite the doubled total cell
titer and corresponding increase in released proteases in
this control protocol). When 0.5  M Ag 85B(241–256)
peptide was added to both sets of fractions during the T
cell assay, BB7 cells responded equally well to both phago-
somal fractions, confirming the presence of equivalent
amounts of I-Ab in these fractions (data not shown). We
conclude that Ag 85B(241–256)–I-Ab complexes are in-
deed generated within phagosomes containing live MTB
and not as an experimental artifact arising after homogeni-
zation of macrophages.
Discussion
MTB uses multiple mechanisms to evade host defenses,
including inhibition of MHC-II expression and Ag pro-
cessing and presentation (5–12), as well as the secretion of
inhibitory cytokines, e.g., IL-10, IL-6, and TGF- . Some
inhibitory mechanisms may not be active during early
stages of macrophage infection but may contribute to
maintenance of chronic infection. For example, MTB 19
kD lipoprotein produces a Toll-like receptor 2–dependent
inhibition of MHC-II Ag processing starting  1 d after
macrophage infection (12). Other mechanisms, including
the ability of MTB to inhibit phagosomal maturation, may
be critical for survival of MTB during earlier stages of mac-
rophage infection. As indicated by our current studies, the
early-stage mechanisms may also include inhibition of phago-
somal Ag processing.
The role of MTB phagosomes in MHC-II processing of
MTB Ag was evaluated by subcellular fractionation cou-
pled with either flow organellometry or MTB-specific T
cell assays with isolated organelles. Plasma membrane and
phagosome fractions were well separated on 27% Percoll
gradients (Fig. 2), and no significant plasma membrane
contamination of the phagosomal fractions was observed
(phagosomal fractions contained  0.015% of plasma mem-
brane marker). As  60% of total MHC-II is on the plasma
membrane (48), contamination of phagosomes with plasma
membrane would have interfered with evaluation of phago-
somal MHC-II levels. The distribution of phagosomes
and MIIC did overlap on 27% Percoll gradients (Fig. 2). As
MIIC contains a significant percentage of intracellular
MHC-II molecules and is a site where MHC-II molecules
bind peptides, additional steps were taken to separate
phagosomes from MIIC. For some experiments, phago-
somes were purified on 40% Percoll gradients, which pro-
duced good separation of phagosomes and MIIC. As 40%
Percoll complicated some procedures, e.g., fixation and
pelleting of phagosomes for flow organellometry, other
experiments used differential centrifugation to separate
phagosomes from smaller membrane structures, e.g., MIIC,
followed by fractionation on 27% Percoll gradients. Both
Figure 7. Ag 85B(241–256)–I-Ab complexes are produced in early phago-
somes at higher levels with HK MTB than with live MTB. (A and B)
Macrophages were pulsed with HK or live MTB for 20 min at a MOI of
either 40 or 13 bacteria per cell and fractionated on separate 27% Percoll
density gradients. Fractions were processed as in Fig. 5 and analyzed for
expression of Ag 85B(241–256)–I-Ab complexes using BB7 T hybridoma
cells. (C) B6D2 and CBA/J macrophages were pulsed with live MTB for
20 min at a MOI of 40, washed and chased for 20 min. The MTB-infected
CBA/J macrophages were mixed with an equal number of naive B6D2
macrophages before homogenization. The two samples were fractionated
on separate 27% Percoll density gradients, and fractions were analyzed for
expression of Ag 85B(241–256)–I-Ab complexes using BB7 T hybridoma
cells.1430 Formation of Peptide–MHC Complexes in M. tuberculosis Phagosomes
approaches provided extremely pure preparations of MTB
phagosomes for our analyses.
These studies provide the first use of flow organellome-
try to analyze bacterial phagosomes (containing MTB, a
significant human pathogen). This technique could poten-
tially be adapted for analysis of phagosomes containing
other types of bacteria. The use of fluorescein-labeled bac-
teria allowed identification of bacterial phagosomes by gat-
ing on fluorescence and optical parameters (reflecting size).
Immunolabeling provided sensitive detection of phago-
somal membrane proteins. Relatively few phagosomes are
required for this type of analysis, allowing the production
of multiple phagosome preparations and their rapid analysis
for a variety of membrane proteins. In addition, subpopula-
tions of phagosomes expressing different levels of mem-
brane proteins can be identified.
Phagosomes containing both HK and live MTB were
analyzed for LAMP-1 as a marker for phagosome matura-
tion. Other reports have shown that phagosomes contain-
ing dead mycobacteria fuse with lysosomes and acquire ly-
sosomal makers (e.g., LAMP-1) in a process termed
phagosome maturation. In contrast, phagosomes contain-
ing live mycobacteria fuse with early endosomes but resist
fusion with lysosomes, i.e., exhibit inhibited phagosome
maturation (13–21) (although they do acquire some
LAMP-1). Activation of macrophages (as done in our stud-
ies to provide for MHC-II expression and Ag presentation)
may decrease the ability of live mycobacteria to inhibit
phagosome maturation (36, 44–47). In our studies, phago-
somes containing HK or live MTB acquired similar low to
moderate levels of LAMP-1 at early time points (e.g., 20
min pulse, 10 min chase). As LAMP-1 is expressed on the
cell surface and in endosomes as well as lysosomes (al-
though it is most highly expressed in lysosomes), live as
well as HK MTB phagosomes could have acquired
LAMP-1 from plasma membrane or endosomes without
lysosomal fusion. Alternatively, phagosomes could have ac-
quired some LAMP-1 by fusion with lysosomes. However,
with longer chase incubations (e.g., 20 min pulse, 100 min
chase) phagosomes containing HK MTB acquired high
levels of LAMP-1 (consistent with phagosome-lysosome
fusion), while live MTB phagosomes lagged in acquisition
of LAMP-1. This lag in acquisition of LAMP-1 suggests
that live MTB may decrease phagosome maturation even
in activated macrophages, although we have not examined
other measures of phagosome maturation. In summary, ac-
tivation of macrophages promotes phagosome maturation
and may decrease the degree to which phagosome matura-
tion is inhibited by live MTB, but our data suggest that
phagosome maturation is still partially inhibited or delayed
even in activated macrophages (this inhibition may not be
evident at much later time points [ 2 h], as examined in
other studies).
Within the time frame of active Ag processing, both live
MTB phagosomes and HK MTB phagosomes acquired
MHC-II molecules that could potentially bind peptides de-
rived from MTB Ags. There was little change in MHC-II
expression by phagosomes from 10 to 110 min of chase
(Fig. 3), suggesting that any delivery of MHC-II molecules
that occurred was essentially balanced by export of MHC-
II from phagosomes (consistent with observations with la-
tex bead phagosomes) (33). Latex bead phagosomes acquire
both newly synthesized MHC-II molecules (primarily from
intracellular compartments) and preexisting MHC-II mole-
cules (primarily from the plasma membrane), but utilize
mostly newly synthesized MHC-II for phagocytic MHC-II
Ag processing (35). Ullrich et al. recently showed that M.
avium–containing phagosomes contain surface-derived,
peptide-loaded MHC-II molecules (36). In our current
analysis the source of MHC-II molecules that are present
and used in MTB processing is still uncertain and may vary
between phagosomes containing live versus HK MTB.
To assess phagosomal Ag processing, macrophages were
incubated with HK or live MTB for various periods and
fractionated on Percoll density gradients. Ag 85B(241–
256)–I-Ab complexes were consistently detected in phago-
somal fractions at 20 min (no chase) and in plasma mem-
brane fractions at later time points. Ag 85B(241–256)–I-Ab
complexes were never detected in other fractions contain-
ing late endocytic compartments, e.g., MIIC, which were
found to contain OVA(323–339)–I-Ad complexes after
macrophage processing of soluble OVA. Thus, in the time
points examined in these studies, MTB peptide–MHC-II
complexes were formed directly within phagosomes that
contained MTB and not in MIIC after export of MTB Ags
from phagosomes.
As phagosomal maturation can be inhibited by live my-
cobacteria, phagosomal processing of live MTB was also
examined. Freshly grown, declumped MTB was used in all
experiments to ensure maximum viability of live MTB
preparations. Both live and HK MTB were processed and
presented to BB7 T cells (Figs. 6 and 7), but processing of
MTB Ag in phagosomes formed with live MTB was
slower and less efficient than in phagosomes formed with
HK MTB. It may seem surprising that live MTB was pro-
cessed at all, but the use of highly activated macrophages in
these studies may have enhanced processing of live MTB
and minimized differences between live and HK MTB in
phagosomal maturation and Ag processing. Previous studies
showed that treatment of macrophages with IFN-  alone,
or with IFN-  and LPS, enhanced acidification of phago-
somes containing live mycobacteria (44–46). Activation of
macrophages with IFN-  substantially increased levels of
mature cathepsin D in live mycobacterial phagosomes, ren-
dering the phagosomes more lysosome like (47). Ullrich et
al. recently showed that treatment of macrophages with
IFN-  promoted acquisition of MHC-II and H2-DM by
live mycobacterial phagosomes (36). Studies comparing
phagosomes isolated from macrophages of different states of
activation may further clarify the effects of live and HK
MTB on phagosomal maturation and MHC-II processing
of MTB Ags.
In conclusion, our observations demonstrate clearly that
MTB phagosomes are fully competent Ag processing or-
ganelles that can mediate the formation of peptide–
MHC-II complexes. Live MTB, however, can inhibit both1431 Ramachandra et al.
phagosome maturation and MHC-II Ag processing. Addi-
tional studies are necessary to understand the mechanisms
of this inhibition and the role of macrophage activation in
potentially decreasing this inhibition. The ability of MTB
to inhibit phagosome maturation and Ag processing may
contribute significantly to survival of MTB in host cells,
providing a major determinant for the virulence of MTB
and its ability to evade host defense mechanisms.
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